A Phase I/II Study of OBI-3424 in Subjects with Advanced Solid Tumors
- Trial ID:
- IRB-22-7924
- Darren Sigal, M.D.
Contact Info:
- Clinical Research Services
- CRSLeadership@scrippshealth.org
Internet Explorer 11 has been retired by Microsoft as of June 15, 2022. To get the best experience on this website, we recommend using a modern browser, such as Safari, Chrome or Edge.